drugset / Trial / NCT02185222

Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint

NCT02185222

Phase 3 Completed 68 enrolled University Hospital, Tours
RandomizedParallel-groupTriple-blindTreatment

Summary

As recommended allowance of oral vitamine D are unable to ensure the recommended serum concentration of vitamine D, the purpose of this study is to show that a dose of vitamin D3 higher than the recommended allowance may slow the cognitive decline of patients with a memory complaint.

Timeline

Start
2014-10-23
Primary completion
2018-10-10
Completion
2018-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 100000 iu Oral